(Q34554716)

3 August 2017

1 reference

title

Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes (English)

1 reference

3 August 2017

Peter G Medveczky

2

0 references

author name string

Christopher M Collins

series ordinal

1

1 reference

3 August 2017

publication date

1 January 2002

1 reference

Advances in Cancer Research

3 August 2017

published in

1 reference

3 August 2017

volume

84

1 reference

3 August 2017

page(s)

155-174

1 reference

Replication of latent Epstein-Barr virus genomes in normal and malignant lymphoid cells

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Selective extraction of polyoma DNA from infected mouse cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Replication initiates at multiple locations on an autonomously replicating plasmid in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Isolation of human sequences that replicate autonomously in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The linking regions of EBNA1 are essential for its support of replication and transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Putting it all together: building a prereplicative complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Organization of terminal reiterations in the virion DNA of herpesvirus saimiri

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The minimal replicator of Epstein-Barr virus oriP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Primary structure of the herpesvirus saimiri genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Plasmid maintenance of derivatives of oriP of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Identification of a herpesvirus Saimiri cis-acting DNA fragment that permits stable replication of episomes in transformed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2802%2984005-2

7 January 2021

10.1016/S0065-230X(02)84005-2

Identifiers

DOI

1 reference

3 August 2017

1 reference